InvestorsHub Logo
Post# of 252498
Next 10
Followers 832
Posts 119983
Boards Moderated 17
Alias Born 09/05/2002

Re: rwwine post# 391

Wednesday, 11/19/2003 9:55:19 AM

Wednesday, November 19, 2003 9:55:19 AM

Post# of 252498
Re: $10 price targets:

>> If we consider the true value of squalamine for AMD which DEW has already suggested based on EYET, and then consider other indications (cancers) for which squalamine appears to be a good candidate, then add IL-9 opportunities for respiratory indications, how can a companies like Fortis and Caris project a valuation of only $10/share?

rwwine: I would not take these price targets too seriously. What Fortis and Caris are saying is that GENR should be trading for at least $10 in the relatively near future, but this does not imply that Fortis and Caris think GENR’s underlying value is limited to $10.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.